FDA on Kratom vs 7-OH: What Its 2025 Announcement Said
The 2025 announcement focused on certain 7-OH products. That distinction matters—and it wasn’t an approval of leaf kratom.
What did the announcement cover?
On July 29, 2025, FDA announced a scheduling recommendation concerning certain 7-OH products. It distinguished that effort from natural leaf products and discussed concentrated products, labeling problems, and forms such as gummies, tablets, and shots.
What didn’t it say?
It didn’t approve natural kratom as a medicine or declare it safe. FDA continues to warn about kratom itself. “This action focused on enhanced 7-OH” and “FDA approved leaf kratom” are very different claims. Only the first describes the scope of that announcement.
A recommendation isn’t a scheduling order
FDA and DEA have different roles. An announcement recommending action doesn’t, by itself, tell you when a scheduling order takes effect. For developments after the 2025 announcement, use the dated October 2026 update and the official documents it links to.
Read a headline with the original nearby
Check the date, substance, and type of action. Look for an effective date where relevant. If a post says every kratom product was banned—or every leaf product was cleared—compare that statement with the actual document before relying on it.
Sources & further reading
For adults 21+. These guides offer general information, not personal medical or legal advice. For a question about your health, medicines, or legal situation, speak with a qualified professional.